Back to search
FDAFDA · Food and drugs·Recall number D-1663-2012

Bracco Diagnostics multihance (gadobenate dimeglumine) injection, 529 mg/mL, 20ml, Rx only, Manufactured for: Bracco Diagnostics Inc., Princeton, NJ 08543 USA, NDC 0270-5164-15

Published September 5, 2012 · Recall initiated: April 16, 2012

Summary

FDA records drug Class III recall D-1663-2012, published September 5, 2012 and initiated April 16, 2012. Recalling firm: Bracco Diagnostics Inc; Status: Terminated; Reported quantity: 47,750 vials; Lot: Lot S1P272A Expiry Date: December 2014. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Short Fill: The product is being recalled due to a potential underfill of the affected vials.

What to do

Voluntary: Firm initiated · Letter

Get an email if MULTIHANCE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
MULTIHANCE
Manufacturer
Bracco Diagnostics Inc
Distributor
Nationwide
Lot
Lot S1P272A Expiry Date: December 2014
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Bracco Diagnostics multihance (gadobenate dimeglumine) injection, 529 mg/mL, 20ml, Rx only, Manufactured for: Bracco Diagnostics Inc., Princeton, NJ 08543 USA, NDC 0270-5164-15 recalled?

Yes. FDA published recall D-1663-2012 on September 5, 2012. Reported hazard: Short Fill: The product is being recalled due to a potential underfill of the affected vials.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: MULTIHANCE.